Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-007629
Filing Date
2019-04-26
Accepted
2019-04-26 10:26:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29121
2 filename2.txt TEXT-EXTRACT 3137
  Complete submission text file 0000000000-19-007629.txt   43872
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filed for) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)